Vertex Pharmaceuticals Inc. buy Guggenheim
Start price
06.08.25
/
50%
€329.95
Target price
06.08.26
€471.96
Performance (%)
14.15%
Price
22:25
€376.65
Summary
This prediction is currently active. The prediction currently has a performance of 14.15%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.643% | -1.643% |
| iShares Core DAX® | 3,02 % | 2,20 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % |
| iShares S&P 500 | 2,64 % | 1,01 % |
Comments by Guggenheim for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Guggenheim from $558.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Guggenheim for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€453.20
02.08.24
02.08.24
€511.18
02.08.25
02.08.25
-11.90%
03.08.25
03.08.25
